Medpace is a pharmaceutical company focusing on clinical development services, research, and biotechnology. Founded in 1992, the Cincinnati-based organization has since grown to become a key player in the industry. The company now boasts 2,800 employees and generates an annual revenue of $1.5 billion.
Under the leadership of CEO August J. Troendle M.D., Medpace has established a diverse workforce with 66.8% female employees and 34.4% ethnic minorities. Despite the lack of political diversity among its staff, the company enjoys high retention rates, with employees typically staying for 4.3 years. The median salary at Medpace is $69,547 per year, which is competitive within the industry when compared to rivals such as Parexel International, Novella, and Pharmaceutical Research Associates, Inc.
